The Food and Drug Administration gave emergency use authorization on Tuesday to Novavax’s new Covid vaccine designed to target the coronavirus’ dominant XBB sublineage, which is fueling a ...

The emergency use listing is based on non-clinical data where the vaccine demonstrated immune responses against variants in ...

Novavax Inc.’s new COVID shot got a green light from the U.S. Food and Drug Administration Tuesday. The FDA authorized the vaccine for people 12 years of age and older, giving individuals ...

GAITHERSBURG, Md., Nov. 28, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based ...

WEDNESDAY, Oct. 4, 2023 (HealthDay News) -- Federal regulators on Tuesday gave the go-ahead to an updated Novavax COVID-19 vaccine, giving Americans a more traditional alternative to two recently ...